These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 16544426)
1. Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice. Lindsay DS; Kaur T; Mitchell SM; Goodwin DG; Strobl J; Dubey JP J Parasitol; 2005 Dec; 91(6):1488-90. PubMed ID: 16544426 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice. Mitchell SM; Zajac AM; Davis WL; Lindsay DS J Parasitol; 2004 Jun; 90(3):639-42. PubMed ID: 15270113 [TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model. Martins-Duarte ÉS; de Souza W; Vommaro RC Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807 [TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo. de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400 [TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine. Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice. Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil. Alves CF; Vitor RW Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831 [TBL] [Abstract][Full Text] [Related]
8. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472 [TBL] [Abstract][Full Text] [Related]
9. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model]. Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis. Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517 [TBL] [Abstract][Full Text] [Related]
11. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models. Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Romand S; Pudney M; Derouin F Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620 [TBL] [Abstract][Full Text] [Related]
13. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts. Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504 [TBL] [Abstract][Full Text] [Related]
14. Azithromycin prophylaxis and treatment of murine toxoplasmosis. Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206 [TBL] [Abstract][Full Text] [Related]
15. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites]. Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918 [TBL] [Abstract][Full Text] [Related]
16. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii. Suzuki Y; Yang Q; Remington JS J Parasitol; 1995 Dec; 81(6):1032-4. PubMed ID: 8544050 [TBL] [Abstract][Full Text] [Related]
17. Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice. Dubey JP; Shen SK; Kwok OC; Frenkel JK J Parasitol; 1999 Aug; 85(4):657-62. PubMed ID: 10461945 [TBL] [Abstract][Full Text] [Related]
18. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii. Khan AA; Lambert LH; Remington JS; Araujo FG Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177 [TBL] [Abstract][Full Text] [Related]
19. Detection of Toxoplasma gondii by polymerase chain reaction in sera of acutely infected mice. Hafid J; Guichard D; Flori P; Bourlet T; Raberin H; Genin C; Sung RT J Parasitol; 2000 Aug; 86(4):857-9. PubMed ID: 10958473 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil. Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]